Riskpilot← Back to searchSign inGet full accessNORAMIX LIAMYRANE 12 AS
ASActiveOrg 914013712Liamyrane 13, 5132 NyborgOther real estate activities on a fee or contract basis · NACE 6832Est. 20140 employees
Revenue 2024
NOK 5,5M
+2% vs 2023
EBITDA margin
72.4%
+22% vs 2023
Equity ratio
73.5%
Financial strength
Net profit 2024
NOK 2,5M
+33% vs 2023
| Revenue | NOK 5,5M | +2% |
| EBITDA | NOK 4M | +22% |
| Net profit | NOK 2,5M | +33% |
| Total assets | NOK 18,2M | +4% |
| Equity | NOK 13,4M | -2% |
| Employees | 0 | — |
Legal name
NORAMIX LIAMYRANE 12 AS
Org number
914013712
Legal form
Aksjeselskap
NACE code
6832 · Other real estate activities on a fee or contract basis
Founded
23. august 2014
Share capital
NOK 790 185
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Utleie av fast eiendom samt kjøp og salg av fast eiendom. Videre skal selskapet kunne kjøpe andeler i andre selskaper.
Address
Liamyrane 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 713 | 4 114 | 4 323 | 5 354 | 5 481 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 1 263 | 2 512 | 2 255 | 3 249 | 3 970 |
| Depreciation & amort. | −710 | −839 | −852 | −894 | −892 |
| EBIT | 553 | 1 673 | 1 403 | 2 355 | 3 078 |
| Net financials | −67 | −71 | −462 | 23 | 92 |
| Profit before tax | 486 | 1 602 | 941 | 2 378 | 3 170 |
| Tax | 107 | 352 | 207 | 523 | 697 |
| Net profit | 379 | 1 249 | 734 | 1 854 | 2 473 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 26 382 | 27 750 | 16 146 | 17 489 | 18 201 |
| Equity | 21 784 | 14 099 | 13 873 | 13 593 | 13 377 |
| Long-term debt | 468 | 416 | 352 | 273 | 212 |
| Short-term debt | 4 130 | 13 235 | 1 920 | 3 622 | 4 611 |
| Total debt | 4 598 | 13 651 | 2 272 | 3 895 | 4 824 |
EBITDA margin
72.4%
This company
15.8%
Market median
+358% vs market
20202024
Equity ratio
73.5%
This company
38.2%
Market median
+92% vs market
20202024
Return on equity
18.5%
This company
18.4%
Market median
+1% vs market
20202024
Net profit margin
45.1%
This company
8.1%
Market median
+457% vs market
20202024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20202024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Deputy Member | Deputy Member | 2015 |
KR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TE Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Noramix Invest AsNoramix Eiendom Holding AsNoramix Eiendom Ii As
NORAMIX LIAMYRANE 12 AS (this company)Board members of NORAMIX LIAMYRANE 12 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Espeseth Rasmussen | Chief Executive Officer | 0 companies |
| Randi Elisabeth Kalvik Rasamanickam | Deputy Member | 0 companies |
| Keerthivarman Rasamanickam | Chief Executive Officer | 0 companies |